ImmunityBio, Inc. (IBRX)

ImmunityBio Employees

As of December 31, 2025, ImmunityBio had 691 total employees, including 684 full-time and 7 part-time employees. The number of employees increased by 11 or 1.62% compared to the previous year.

• Employees: 691
• Change: 11
• Growth: 1.62%
• Revenue / Employee: $204,019
• Profits / Employee: -$1,236,663
• Market Cap: 7.52B

Employees History

Date	Employees	Change (1Y)	Growth (1Y)	Full-Time	Part-Time
Dec 31, 2025	691	11	1.62%	684	7
Sep 30, 2025	673	1	0.15%	673	0
Jun 30, 2025	685	63	10.13%	685	0
Mar 31, 2025	671	43	6.85%	671	0
Dec 31, 2024	680	52	8.28%	680	0
Sep 30, 2024	672	2	0.30%	672	0
Jun 30, 2024	622	-61	-8.93%	622	0
Mar 31, 2024	628	-75	-10.67%	628	0
Dec 31, 2023	628	-97	-13.38%	628	0
Sep 30, 2023	670	-90	-11.84%	670	0
Jun 30, 2023	683	-57	-7.70%	683	0
Mar 31, 2023	703	15	2.18%	703	0
Dec 31, 2022	725	138	23.51%	725	0
Sep 30, 2022	760	222	41.26%	760	0
Jun 30, 2022	740	229	44.81%	740	0
Mar 31, 2022	688	213	44.84%	688	0
Dec 31, 2021	587	138	30.73%	587	0
Sep 30, 2021	538	273	103.02%	538	0
Jun 30, 2021	511	246	92.83%	511	0
Mar 31, 2021	475	210	79.25%	475	0

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Employee data is provided by S&P Global Market Intelligence and updates every three months after the filing of each quarterly report.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error